Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele

Peter Carmeliet; Valérie Ferreira; Georg Breier; Saskia Pollefeyt; L Kieckens; Marina Gertsenstein; Michaela Fahrig; Ann Vandenhoeck; Kendraprasad Harpal; Carmen Eberhardt; Cathérine Declercq; Judy Pawling; Lieve Moons; Désiré Collen; Werner Risau; András Nagy

doi:10.1038/380435a0

Related publications

Article2005

Gene targeting of VEGF-A in thymus epithelium disrupts thymus blood vessel architecture

Susanna Müller, Grzegorz Terszowski, Carmen Blum, Corinne Haller, Viviane Anquez, Stephen Kuschert, Peter Carmeliet, Hellmut G. Augustin, Hans-Reimer Rodewald

Article2003

Aberrant Inflammation and Lethality to Septic Peritonitis in Mice Lacking STAT3 in Macrophages and Neutrophils

Akihiro Matsukawa, Kiyoshi Takeda, Shinji Kudo, Takako Maeda, Motoko Kagayama, Akira Shizuo

The Journal of Immunology

Article1996

Role of tissue factor in embryonic blood vessel development

Peter Carmeliet, Nigel Mackman, Lieve Moons, Thomas Luther, Pierre Gressèns, Lise Van Vlaenderen, Hilde Demunck, Michael Kasper, Georg Breier, Philippe Evrard, Martin Müller, Werner Risau, Thomas S. Edgington, Désiré Collen

Article2021

Development of alginate-based hydrogels for blood vessel engineering

I.M.H.R. Antunes, Walter Bonani, Rui L Reis, Claudio Migliaresi, Helena Ferreira, Antonella Motta, Nuno M. Neves

Article2017

How glucose, glutamine and fatty acid metabolism shape blood and lymph vessel development

Laure-Anne Teuwen, Vincent Geldhof, Peter Carmeliet